Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.896
-0.014 (-1.58%)
At close: Jan 21, 2025, 4:00 PM
0.863
-0.033 (-3.70%)
After-hours: Jan 21, 2025, 5:06 PM EST
Spero Therapeutics Employees
Spero Therapeutics had 46 employees as of December 31, 2023. The number of employees increased by 11 or 31.43% compared to the previous year.
Employees
46
Change (1Y)
11
Growth (1Y)
31.43%
Revenue / Employee
$2,314,239
Profits / Employee
$76,370
Market Cap
48.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
SPRO News
- 2 days ago - Spero Therapeutics: Undervalued Based On Just Tebipenem And GSK Deal - Seeking Alpha
- 11 days ago - Spero Therapeutics Provides Business Update and Announces Interim Leadership Changes - GlobeNewsWire
- 2 months ago - Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024 - GlobeNewsWire
- 3 months ago - Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy - GlobeNewsWire
- 5 months ago - Spero Therapeutics, Inc. (SPRO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 6 months ago - Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024 - GlobeNewsWire